SynBiotic SE (FRA:SBX)

Market Cap	5.26M -71.6%
Revenue (ttm)	14.86M +171.5%
Net Income	-9.72M
EPS	-1.66
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,218
Open	0.7960
Previous Close	0.8150
Day's Range	0.7480 - 0.8010
52-Week Range	0.5810 - 3.6450
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 16, 2026

About SynBiotic SE

SynBiotic SE, together with its subsidiaries, engages in the pharmaceutical business in Germany and Europe. It is involved in the cultivation, research, development, production, and distribution of medicinal cannabis; industrial hemp; and cannabidiol and cannabinoid-based products. The company was incorporated in 2024 and is based in Düsseldorf, Germany.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2024
• Employees: 79
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SBX

Financial Performance

In 2024, SynBiotic SE's revenue was 14.86 million, an increase of 269.31% compared to the previous year's 4.02 million. Losses were -9.72 million, -8.60% less than in 2023.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 13, 2026

Data Sources Report a data error